Point72 Asset Management, L.P. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,033,000
-56.9%
2,750,000
-37.1%
0.02%
-54.3%
Q1 2022$11,671,000
-57.2%
4,371,300
-30.6%
0.05%
-57.8%
Q4 2021$27,292,000
-14.9%
6,303,0250.0%0.11%
-22.7%
Q3 2021$32,082,000
-20.7%
6,303,025
-1.4%
0.14%
-22.5%
Q2 2021$40,473,000
-17.4%
6,393,900
+0.9%
0.18%
-20.5%
Q1 2021$48,970,000
+5879.2%
6,335,000
+4968.0%
0.23%
+5625.0%
Q4 2020$819,000
-90.5%
125,000
-87.9%
0.00%
-92.9%
Q2 2020$8,608,000
+418.2%
1,033,406
+377.2%
0.06%
+330.8%
Q1 2020$1,661,000
-72.3%
216,564
-70.0%
0.01%
-59.4%
Q4 2019$5,992,000
+61.6%
721,000
+118.2%
0.03%
+68.4%
Q2 2019$3,708,000
-44.9%
330,498
-47.2%
0.02%
-38.7%
Q1 2019$6,726,000
-69.6%
625,649
-57.3%
0.03%
-71.3%
Q4 2018$22,103,000
-10.0%
1,463,796
+10.2%
0.11%
+6.9%
Q3 2018$24,563,000
+579.3%
1,327,740
+739.4%
0.10%
+621.4%
Q2 2018$3,616,000158,1710.01%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders